WCM Investment Management
CYTK icon

WCM Investment Management’s Cytokinetics CYTK Stock Holding History

WCM Investment Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-71,794
Closed -$3.76M – 299
2024
Q3 		$3.76M Sell
71,794
-5,019
-7% -$280K 0.01% 175
2024
Q2 		$4.13M Buy
76,813
+32,947
+75% +$1.99M 0.01% 168
2024
Q1 		$3.08M Buy
+43,866
New +$3.39M 0.01% 176

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

WCM Investment Management's CYTK Position: Q4 2024 in Review

WCM Investment Management sold out of Cytokinetics (CYTK) in Q4 2024, closing a stake of 71,794 shares — an estimated $3.76M sold.

WCM Investment Management first reported a position in CYTK in Q1 2024 and held it in 3 quarters. The position peaked at $4.13M in Q2 2024. 346 funds tracked by Wall St. Rank hold CYTK as of Q4 2024.

  • WCM Investment Management reported no remaining Cytokinetics position as of Q4 2024 after selling out during the quarter.
  • WCM Investment Management sold 71,794 Cytokinetics shares in Q4 2024, an estimated $3.76M.
  • WCM Investment Management first reported a position in Cytokinetics in Q1 2024 and held it in 3 quarters.
  • WCM Investment Management's Cytokinetics position peaked at $4.13M in Q2 2024.
  • 346 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2024.

Based on WCM Investment Management's 13F filing for Q4 2024, filed 28 Jan 2025.